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We sequenced the envelope (env) gene and 3' long terminal repeat of a Friend mink cell focus-inducing
virus (F-MCFV). We also sequenced the gp7O coding regions for two cDNA clones of another F-MCFV.
The deduced amino acid sequence of the env gene products of both F-MCFVs were compared to the
corresponding sequences of other MCFVs and of ecotropic viruses. The env polypeptides of the different
viruses showed long stretches of homology in the carboxy-terminal half of gp7O and in p15env ("constant
region"). The amino-terminal half of gp7O was very similar in all MCFVs, but showed extensive variations
relative to the ecotropic viruses ("differential region"). This differential region in all MCFVs is of
endogeneous origin. We show evidence that this region carries determinants for ecotropic or polytropic host
range. No indication could be found that the env gene products determine the histological type of disease
caused by particular MCFVs. When the long terminal repeats of F-MCFV and Friend murine leukemia virus
were compared with those of other viruses causing either lymphatic leukemia or erythroleukemia, several
nucleotides were localized which might determine the histological type of disease caused by these viruses.
Mink cell focus-inducing viruses (MCFVs) are polytropic
viruses, able to induce cytopathic foci when grown on mink
lung fibroblasts (16). The association between a variety of
leukemias and MCFVs is becoming increasingly apparent.
MCFVs have been implicated in the generation of thymic
lymphomas in AKR mice and in the leukemias induced by
Moloney murine leukemia virus (M-MuLV), Rauscher
MuLV, and Friend MuLV (F-MuLV) (7, 12, 50). Antigenic
and tryptic peptide analysis of viral gene products, RNase T,
oligonucleotide mapping, and heteroduplex, restriction en-
zyme, and sequence analyses reveal that MCFVs are recom-
binants between ecotropic MuLVs and endogenous xenotro-
pic virus-like sequences (7, 12, 50).
F-MuLV is an ecotropic, helper-independent, type C
retrovirus which induces erythroleukemia at a high rate in
newborn mice and lymphatic leukemia with a long latency in
adult mice (53). A subgenomic DNA fragment of F-MuLV
containing the 3' portion of the polymerase (pot) gene, the
env gene, a single long terminal repeat (LTR), and the 5'
portion of the gag gene carries the pathogenic functions of F-
MuLV (33). A 2.4-kilobase-pair DNA fragment ranging from
the 3' portion of the pol gene to the 3' portion of the env gene
contains sufficient information to convert a nonpathogenic
MuLV into a leukemia-inducing virus (34). However, these
sequences are not sufficient to impart the high disease
incidence and brief latency period of F-MuLV to other
MuLVs. These properties must be specified by other se-
quences in the F-MuLV genome.
The onset of erythroleukemia in mice infected with F-
MuLV is invariably associated with the generation of Friend
MCFV (F-MCFV) (40, 42, 54). F-MuLV replicates to high
titers in both resistant strains of mice and in strains that are
susceptible to F-MuLV-induced disease; however, F-MCFV
is only generated in susceptible strains of mice (40, 41). F-
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MCFV itself induces the same type of erythroproliferative
disease as F-MuLV. Resistance to this disease correlates
with the endogenous expression of a xenotropic-like gp7O-
related protein that may interfere with the replication or
spread of F-MCFV. These results suggest that F-MCFV is a
crucial intermediate in the induction of disease by F-MuLV.
Restriction enzyme analysis of a molecularly cloned F-
MCFV (clone pFM54B) indicates that a DNA fragment of F-
MuLV containing most of the env gene has been replaced by
endogenous env-like sequences (31). To better understand
recombined env genes, we sequenced this region of the F-
MCFV genome. In addition, we sequenced two cDNA
clones of the env gene of an F-MCFV which we observed in
an established Friend virus-infected cell line (45). To identify
the sequences which may specify the histological type of
leukemia caused by F-MuLV and F-MCFV, the LTR re-
gions of these viruses were also sequenced. These sequences
were compared with the LTR sequences of other lymphatic
leukemia- and erythroleukemia-inducing murine retrovi-
ruses.
MATERIALS AND METHODS
Virus and plasmid. F-MCFV is a helper-independent,
polytropic retrovirus which was isolated from a leukemic
NIH Swiss mouse after inoculation with a biologically
cloned F-MuLV isolate, F-MuLV 201. F-MCFV DNA was
molecularly cloned in pBR322 as described (31). One of the
resulting clones, pFM54B, which represents a genomic clone
of F-MCFV containing a single LTR, was used for sequenc-
ing. F-MuLV clone 57 is a helper-independent, ecotropic,
highly leukemogenic virus which induces erythroleukemia
after inoculation into newborn NIH Swiss mice in the
absence of spleen focus-forming virus (SFFV) (32, 33). F-
MuLV 57 DNA (pF-MuLV57) was molecularly cloned from
viral DNA isolated from fibroblasts infected with F-MuLV
clone 201. pF-MuLV57 is a genomic clone which carries a
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single LTR (33). pF-MuLV57 was used for all F-MuLV
sequence analyses.
Cloning of viral mRNA. Polyadenylate-containing RNA
from the Eveline cell line, a Friend virus-infected cell line
from an STU mouse (45), was prepared as described by
Chirgwin et al. (5). Double stranded cDNA was synthesized
and tailed with 3'-dCMP and ligated to vector DNA by the
method of Land et al. (21). pBR322 and pBR327 (47) cut with
PstI and tailed with 3'-dGMP were used as vectors for
constructing recombinant plasmids. Tetracycline-resistant
(ampicillin-sensitive) transformants were screened by colo-
ny hybridization (14). A nick-translated DNA fragment of
pF-MuLV57 (HindIII-KpnI fragment of 3,300 base pairs
[bp]) (20) was used to probe for plasmids containing F-
MuLV env gene sequences. Two clones (pFM1 and pFM2)
were obtained which hybridized to the F-MuLV probe.
Cloning of pFM2 in ml3mp8 and dideoxy sequencing. The
PstI double-stranded cDNA insert of pFM2 was reinserted
into the PstI site of ml3mp8 replicative-form DNA (J.
Messing, Methods Enzymol., in press), and recombinants
were transfected into Escherichia coli JM103 (27). Bacteria
from white plaques were grown in small cultures and
screened for ml3mp8 replicative-form DNA containing in-
serts by using a miniscreen procedure (2). Single-stranded
phage DNA was isolated from the cultures and sequenced
according to the dideoxy nucleotide chain-terminating pro-
cedure developed by Sanger et al. (43), using a primer
consisting of 15 nucleotides (Bethesda Research Labora-
tories, Gaithersburg, Md.).
Restriction enzyme analysis. Preparation of plasmid DNA
for restriction enzyme analysis and sequencing was per-
formed as previously described (20). Restriction endonucle-
ases were obtained from Bethesda Research Laboratories,
Gaithersburg, Md., Boehringer Mannheim, Mannheim,
West Germany, and New England Biolabs, Beverly, Mass.,
and were used according to the specifications of the manu-
facturer. Restriction enzyme analysis of DNA was per-
formed as described (20).
DNA sequencing by base-specific chemical cleavages. Se-
quence analysis of the envelope genes of plasmids pFM54B
and pFM1 and of the LTR regions of pFM54B and pF-
MuLV57 was performed by base-specific chemical cleav-
ages (26). Restriction enzyme fragments were terminally
labeled with [y-32P]ATP (Amersham Radiochemical Centre,
Amersham, England) and T4 polynucleotide kinase (Bethes-
da Research Laboratories). A+G, G, A>C, C>T, and C+T
reactions were used for base-specific modifications.
RESULTS AND DISCUSSION
Sequence determination of the env gene and joining regions
of F-MCFV. Comparison of the restriction enzyme maps of
pFM54B (31) and pF-MuLV57 (20, 31) indicated that the env
gene and LTR of pFM54B were located within a region
ranging from the single SphI site to the HindlIl site in the
gag gene. A detailed restriction enzyme analysis of this
region was performed (Fig. 1C). Nucleotide sequences of the
3' terminus of the pol gene, the env gene, and the LTR of
pFM54J3 were determined by using the method of Maxam
and Gilbert (26). The sequencing strategy is shown in Fig.
1C. The env-specific PstI insert of pFM1 (about 1,400 bp)
was mapped by digestion with restriction endonucleases
(Fig. 1B). Comparison of the restriction enzyme maps of
pFM1 (Fig. 1B) and pFM54B (Fig. 1C) suggested that pFM1
contained the region coding for gp7O of F-MCFV. The PstI
insert of pFM1 was sequenced according to the method of
Maxam and Gilbert (26). The sequencing strategy is shown
in Fig. 1B. The env-specific PstI insert of pFM2 (about 400
bp) was recloned into the PstI site of ml3mp8 replicative-
form DNA. Both strands of the insert were sequenced by
using the method of Sanger et al. (43). Comparison of the
overlapping sequences of pFM2 and pFM1 revealed that
both clones were identical in this region (see below). Thus,
we assumed that pFM1 and pFM2 are derived from identical
F-MCFV genomes. In addition to the sequence coding for
the amino terminus of gp7O, pFM2 contains the region
coding for the peptide leader of the env polyprotein. A
restriction enzyme map of the PstI insert of pFM2 is shown
in Fig. 1A. The nucleotide sequences of the envelope genes
and joining regions of pFM54B and pFM1/pFM2 are shown
in Fig. 2.
Sequence determination of the LTR of F-MuLV and of a
region 5' to the env gene. Restriction enzyme maps of the 3'-
terminal portion of the pol gene, the env gene, the LTR of F-
MuLV, and the nucleotide sequence of the env gene of F-
MuLV have been published before (20, 24, 31, 32). We
determined the sequence of the 3' terminus of the pol gene
and the sequence of the LTR of pF-MuLV57. The restriction
enzyme maps and the sequencing strategies for these regions
are shown in Fig. 1D.
3'-Terminal portion of the pol gene of F-MCFV (pFM54B)
and F-MuLV. Figure 3 shows the nucleotide sequences of
the 3'-terminal regions of the pol genes and the 5'-terminal
regions of the env genes of F-MCFV (pFM54B) and F-
MuLV. The pol gene and env gene overlap by 58 nucleotides
(19 1/3 codons) in both viral genomes. Within the overlap-
ping region of pol and env genes, there are 13 differences in
the nucleotide sequences of F-MCFV and F-MuLV. These
differences lead to 12 amino acid differences in the frame
coding for the env polypeptide but to only 3 differences in the
frame coding for the DNA polymerase. Thus, the carboxy-
terminal region of the polymerase is conserved to a higher
degree than the amino terminus of the env polypeptide.
LTRs of F-MCFV and F-MuLV. Retroviral LTRs appear
to contain sequences that control synthesis of progeny viral
RNA and viral mRNA, reverse transcription of viral RNA
by DNA polymerase, and integration of viral DNA into
cellular DNA and contribute to the pathogenic potential of
retroviruses (8, 33, 51, 52). In addition, U3 sequences can
influence the tissue tropism exhibited by some murine
leukemia viruses (4, 9). Presumably, these sequences con-
tain tissue-specific transcriptional enhancers which control
the level of viral gene expression in different target cells.
LTRs of several species of retroviruses differ in size and
nucleotide sequence (6, 10, 18, 48, 49, 56). Despite these
differences, certain nucleotide sequences which are believed
to be important for the functions mentioned above are
present in the LTRs of different virus species (8, 51, 52).
We sequenced the LTRs of F-MCFV (pFM54B) and F-
MuLV (pF-MuLV57) (Fig. 2 and 4). By comparison with
known sequences, we localized the regions U3-R-U5, where
U3 and U5 designate unique sequences originating from the
3' and 5' ends, respectively, of viral RNA and R designates a
sequence of viral RNA that is redundant at both ends. The
nucleotide sequences of the LTRs of F-MCFV and F-MuLV
were very similar to the sequences obtained for other murine
(3, 6, 22, 46) and feline (11, 15; M. Wunsch, A. S. Schulz, W.
Koch, R. Friedrich, and G. Hunsmann, EMBO J., in press)
retroviruses and contained the putative control elements
generally present in retroviral LTRs (8, 52). The LTR of F-
MCFV consists of 514 bp. The LTR of F-MuLV contains 591
bp. The U3 regions of both LTRs start with 13 nucleotides
VOL. 49, 1984
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which are found as an inverted repeat at the 3' termini of the
U5 regions. This inverted repeat is also contained in the
LTRs of several other murine (3, 6, 11, 15, 22, 46) and feline
(11, 15) retroviruses. The U3 of F-MuLV contains a stretch
of 65 nucleotide pairs which is repeated in tandem. As
suggested for similar direct repeat sequences in the U3 of
other retroviruses, this region presumably has an enhancer
function for effective expression of the proviral DNA (8, 52).
F-MCFV contains no direct repeat. The 3' portion of the
direct repeat of F-MuLV has an insert of nine nucleotide
pairs which is part of a small, nearly perfect direct repeat.
A CAT and a TATA box, which presumably are necessary
200
A pFM2
600 1000
for the initiation of transcription (8, 52), are located in the U3
of F-MCFV and F-MuLV. A possible Z-DNA segment
which is believed to be involved in regulation of transcrip-
tion (30) is also present in the U3 region of F-MCFV and F-
MuLV. Signals which are hypothesized to be involved in
polyadenylation of viral RNA (AATAAA, 22 bp before the
start of U5, and CA, at the very end of R) are found in F-
MCFV and F-MuLV.
Sequences in the LTR as possible determinants of the
histological type of leukemia. When we aligned the LTRs of
F-MCFV and F-MuLV with the LTRs of the lymphatic-
inducing viruses Moloney MCFV (M-MCFV) and M-MuLV
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FIG. 1. Physical mapping and use of restriction enzyme fragments for sequence analyses. Closed circles represent oligonucleotide primers
used for polymerization reactions (dideoxy nucleotide sequencing). Open circles represent 5' ends labeled with [-y-32P]ATP (sequencing with
base-specific chemical cleavages). Arrows indicate fragments from which unambiguous sequences were obtained. (A) Restriction
endonuclease cleavage sites of the env-specific PstI insert of clone pFM2. (B) Restriction endonuclease cleavage sites of the env-specific PstI
insert of clone pFM1. (C) Restriction endonuclease cleavage sites of the SphI-HindIII fragment of pFM54B containing the env gene and LTR
of F-MCFV. A triangle indicates the 74-bp deletion in the LTR of F-MCFV with respect to F-MuLV. (D) Restriction endonuclease cleavage
sites of the 3' end of the pol gene and the LTR of F-MuLV within the SphI-HindIII fragment. The numbers in and near the LTRs of F-MCFV
(C) and F-MuLV (D) indicate functional regions as follows: 1 and 8, inverted repeats at the ends of the LTRs; 2 and 3, direct repeats in the U3
of F-MuLV; 4, CAT box; 5, putative Z-DNA segment; 6, TATA box; 7, polyadenylation signal; 9, primer binding site for minus-strand
synthesis; 10, splice donor site for generation of subgenomic 21S mRNA. Abbreviations: CHO, potential glycosylation site; A, AccI; Ba,
BamHI; Bg, Bgll; Cf, CfoI; Cl, ClaI; E, EcoRI; H, HindIII; K, KpnI; M, MboII; Ps, PstI; (Ps), PstI site generated by cloning; Pv, PvuII; Sm,
SmaI; Sp, SphI; SI, Sstl; SII, SstIl; T, TthlllI; X, XbaI.
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XbaI
AGTGTGGGTCCGCAGACACCAAACTAAAAiTCTAGAACCECGCTGGAAAaGACCCTACACCGTCCTGCTGACCACCCCCACCGCTCTCAA 90
C2 T C---GA A CAG ATT AGC .C C A T CGAGTAGACGGCATCGCTGCGCGGATCCACGECGCTCACGTAAAAGCGGCGACAACCCCTCCGGCCGGAACAGCATCAGGACCGACATGGAA 180
MetGluleader Ala
T T A A A r-wPFNf,GGTCCAGCGTTCTCAAAACCCCTTAAAGATAAGATTAACCCGTGGGGCCCCCTGATAGTCCTGGGGATCTTAATAAGGGCAGGAGTATCi 270
-30 ClyProAlaPheserLysproLeuLysAspLysIleAsnProTrpGlyProLeulleValLeuGlylleLeuIleArgAlaGlyValSer
CysSerThr Ilie
AGTACCACATGACAGCCCTCATCAGGTCTT'CAATGTTACTTGGAGAGTTAECAACTTAATaACAGGACAAACAGCTAATGETACCTCCCTC 360gp Va1VlProHisAspSerProHisGlnValPhe snVa TfWlTrpArgValThrAsnLeuMetThrGlyGlnThrAl AsnAlaTjs erLeu
TCTGGGGACAiTGACCGATGCCTTTCCCAAACTGTACTTTGACTTGTGCGATTTAATAGGCGACGACTGGCATGAGACTGCACTCGGGTGT 45031 LeuGlyThrMetThrAspAlaPheProLysLeuTyrPheAspLeuCysAspLeu leGClyAspAspTrpAspGluThrGlyLeuGlyCys
end pFN2-
CGCACTCCCGGGGGAAGAAiAAGGGCAAGjACATTTGACiTCTATGTTTGCCCCGGGCATACTGTACCAACAGGGTGTGGAGGCCCGAGA 54 061 ArgThrProGlyGlyArgLysArgAlaArgThrPheAspPheTyrValCysProGlyHisThrValProThrGlyCysGlyGlyProArgAla
TGAGGGCTACTGTGGCAAATGGGCCTGTGAGACCACTGGACAGGCATACTGCAAGCCATCATCATCATGGGACCTAATTTCCCTTAAGCGA 630
91 GluGlyTyrCysGlyLysTrpGlyCysGluThrThrGlyGlnAlaTyrTrpLysproserserserTrpAspLeulleSerLeuLysArg
Leu
* A A .A CGGAAACACCCCTCGGAATCAGGGCCCCTGTTATGATTCCTCAGCGGTCTCCAGTGGCATCCAGGGTGCCCACACCGGGGGGTCGATGCAAT 720
121 GlyAsnThrProArgAsnGlnGlyProCysTyrAspSerSerAlavalSerSerGlyI leGlnGlyAlaThrProGlyGlyArgCysAsnGln Asp LysG . C . C CGCCCCTAGTCCTAGAATTCACTGACGCGGGTAAAAAGGCCAGCTGGGATGGCCCCAAAGTATGGGGACTAAGACTGTACCGATCCACAGGA 810
151 ProLeuValLeuGluPheThrAspAlaGlyLysLysAlaserTrpAspGlyProLysValTrpGlyLeuArgLeuTyrArgSerThrGly
G C. TACCGACCCGGTGACCCGGTTCTCTTTGACCCGCCAGGTCCTCAATATAGGGCCCCCGCATCCCCATTGGGCCTAATCCCG'TGATCA-TGAC 900
181 ThrAspProValThrArgPheSerLeuThrArgGlInValLeuAsnIleGlyProArgIleProIleGlyProAsnProVallleThrAsp
Arg Val Ile
C T .C GTCCCTGAGACTCAGTTACCCCCCTCCCGACCCGTGCAGATCATGCTCCCCAGGCCTCCTCAGCCTTCCCCTACAGGCGCAGCCTCTATA 978
211 GlnLeuProProSerArgProValGlnI leMetLeuProArgProProGlnProSerProThrGlyAlaAlaSer lle
Pro Pro ValProGluThrGCCCCACCTTCTCAA CG T. CCAACCTGGGACGGGAGACAGACTGCTAAACCTGGTAGATGGAGCCTACCAAGCACTCAACCTCACCAGTCCTGAC 1 053
237 GCnProGlyThrGlyAspArgLeuLeuAsnLeuValAspGlyAlaTyrGlnAlaLei4AiiTi'FlF'erProAspAlaProProSerGIn G. A .T TAAAACCCAAGACTGCTGGTTGTGTCTGGTATCGGGACCCCCCTACTACGCAGGGGTTGCCGTCCTAGGTACCTACTCC AACCATCT 1143
262 LysThrGlnGluCysTrpLeuCysLeuValSerGlyProProTyrTyrGluGlyValAlaValLeuGlyThrTyrSe AsnHisThr|Ser
AlaGlu
A. T A. G T GA A A. G A.GCCCCAGCTAACTGCTCCGTGGCCTCCCAACACAAGCTGACCCTGTCCGAAGTAACCGGACAGGGACTCTGCGTAGGAGCAGTTCCCAAA 1233
292 AlaProAlaAsnCysSerValAlaSerGCnHisLysLeuThrLeuSerGluValThrGlyGlnGlyLeuCysValGlyAlaValProLysIA IV Arg Ile Thr
T C C.C T TT G A AA T. A T. C A. A T CG . G TACCCATCAGGCCCTGTGTATAACCACCCAGAATA.CAACGACGGGTCCTACTATCTGGCTGCTCCCGCCGGGACCATTTGGGCTTGCAAC 1323
322 ThrHisGlnAlaLeuCysAsnThrThrGlnC1soTthrerlAspGlySerTyrTyrLeuAlaAlaProAlaGlyThrIleTrpAlaCysAsnI ILeuLys AsnLys Val Thr
C A A T. CG C C G T T.G T.C T C T C A AT A CC C 1ACTGGGCTCACTCCCTGCCTATCTACTACTGTACTCAACCTCACCACCGATTACTGTGTCCTGGTTGAGCTCTGGCCAAAGGTGACCTAC 1413
352 ThrGlyLeuThrProCysLeuSerThrThrValLe snLeuTr hrAspTyrCysValLeuValGluLeuTrpProLysValThrTyr
Ala Argq Arg
TC T CA C C . A A A TCCTAT G C T. A A C .CT T.AT A A TCACTCCCCTGGTTATGTTTATGGCCAGTTTGAGAGAAAAACCAAATATAAAAGAGAGCCGGTGTCATTAACTCTGGCCCTGCTGTTCGGA 1503
382 HisSerProGlyTyrValTyrGlyGlnPheGluArgLysThrLysTyrLysArgGluProValSerLeuThrLeuAlaLeuLeuLeuGly
Pro Ser Ser LysSerTyrArgHis JL--PI5env/Pi2envend gp70 end 'pF1/1G A T .CC. . TGGACTTACTATGGGCGGCATAGCTGCAGGAGTAGGGACAGGAACTACCGCCCTGGTCGCCACCCAGCAGTTCCAGCAGCTCCATGCTGCC 1593
412 GlyLeuThrMetGlyGlyI eAlaAlaGlyValGlyThrGlyThrThrAlaLeuValAlaThrGlnGlnPheGlnGlnLeuHisAlaAla
GTACAAGATGATCTCAAAGAAGTCGAAAAGTCAATTACTAACCTAGAAAAGTCTCTTACTTCGTTGTCTGAGGTTGTGCTGCAGAATCGA 1683
442 ValGlnAspAspLeuLysGluValGluLysSerIleThrAsnLeuGluLysSerLeuThrSerLeuSerGluValValLeuGlnAsnArg
CGAGGCCTACACCTGTTGTTCCTAAAAGAAAGAGGACTGCGTGCTGCCCTAAAAGAAGAATGTTGTTTCTATGCTGACCATACAGGCCTA 1773
472 ArgGlyLeuAspLeuLeuPheLeuLysGluArgGlyLeuCysAlaAlaLeuLysGluGluCysCysPheTyrAlaAspHisThrGlyLeu
GTAAGAGATAGTATGGCCAAATTAAGAGAGAGACTCACTCAGAGACAAAAACTATTTGAGTCGAGCCAAGGATGGTTCGAAGGATTGTTT 1863
502 ValArgAspSerMetAlaLysLeuArgGluArgLeuThrGlnArgGlnLysLeuPheGluSerSerGlnGlyTrpPheGluGlyLeuPhe
AACAGATCCCCCTGGTTTACCACGTTAATATCCACCATCATCGGGCCTCTCATTATACTCCTACTAATTCTGCTTTTTGGACCCTGCATT 1953
532 jAsnArgSerilroTrpPheThrThrLeuIleSerThrIleMetGlyProLeullelleLeuLeuLeulleLeuLeuPheGlyProCysIle
CTTAATCGATTAGTTCAATTTGTTAAAGACAGGATCTCAGTAGTCCAGGCTTTAGTCCTGACTCAACAATACCACCAGCTAAAACCACTA 2043
562 LeuAsnArgLeuValGlnPheValLysAspArgIleSerValValCInAlaLeuValLeuThrGlnGlnTyrHisGlnLeuLysProLeu
end pl2env*. r- LTR -U3GAATACGAGCCATGATAAATAAAAGATTTTATTTAGTTTCCAGAAAAACGGGGGAATGAAAGACCCCACCAAGTTGCTTAGCCTGATAGC 2133
592 GluTyrGluPro end pl5env
CGCAGTAACGCCATTTTGCAAGGCATGGAAAAATACCAAACCAAGAATAGGGAAGTTCAGATCAAGGGCGCGTACACGAAAACAGCTAAC 2223
GTTGGGCCAAACAAGATATCTGCGGTAAGCAGTTTCGGCCCCGGCCCGGGGCCAAGAACAGATGGTCCCCAGATATGGCCCAACCCTCAG 2313
CAGTTTCTTAAGACCCATCAGATGTTTCCAGGCTCCCCCAAGGACCTGAAATGACCCTGTGCCTTATTTAAATTAACCAATCAGCCCGCT 2403
TCTCGCTTCTGTTCGCGCCCTTTTGCTTCCCGAGCTCTATAAAAGAGCTCACAACCCCTCACTCGGCGCGCCAGTCCTACAGACTGAGTL 2'4q3R ',r_' USGCCCGGGTACCCGTGTATCCAATAAATCCTCTTGCTGTTGCATCCGACTTGTGGTCTCGCTGTTCCTTGGCAGGGTCTCCTCAGAGTGAT 2583
u5 - LrT-TGACTACCCGTCTCGGGGGTCTTTCATTTGGGGGCTCGTCCGGGATCTGGAGACCCTTGCCCAAGGACCACCGACCCACCACCGGGAGGT 2b73
FIG. 2. Nucleotide sequence and deduced amino acid sequence of the env gene of F-MCFV (pFM54B). Differing nucleotides and amino
acids of pFM1 and pFM2 are also shown. Regions of uncharged amino acids are underlined. Potential glycosylation sites are enclosed in
boxes. The sequence presented here differs from the preliminary sequence distributed at the Cold Spring Harbor RNA Tumor Virus Meeting
in May 1983 at positions 896, 1539, and 1969. Also given is the nucleotide sequence of the LTR of F-MCFV (pFM54B).
(Fig. 4) we found a high degree of homology between the tandem direct repeat flanked by small direct repeats, where-
LTR sequences. However, some nucleotide exchanges as as F-MuLV has a tandem direct repeat which contains a few
well as insertions and deletions were observed. Most differ- mismatches and a 9-bp insertion/deletion. Neither F-MCFV
ences were in the U3 regions. M-MuLV has a perfect major nor M-MCFV showed a large direct repeat. Since M-MCFV
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* 0* 00 0 0 0
1 F-NCPV CCCACCGCTTCTAAAGTAGACGGCATCGCTGCGTGGATCCACGCCGCTCACGTAAAAGCGGCGACAACCCCTCCGGCCGGA
ProThrAlaLeuLysValAspGlylleAlaAlaTrpIleGlnAlaAlaHisValLysAlaAlaThrThrProProAlaGly
2 F-NuLV * * * * * * * * * * * * * * * * * * * * * AspThrArgIleGlu
.......................... ................... ...........C GA.A.CAG.ATT.AG
* * 0 0 * * 0
1 ACAGCATCAGGACCGACATGGAAGGTCCAGCGTTCTCAAAACCCCTTAAAGATAAGATTAACCCGTGGGGCCCCCTAATAGTCCTGGGGA
env polypeptide MetGluGlyProAlaPheSerLysProLeuLysAspLysIleAsnProTrpGlyProLeuIleValLeuGly
ThrAlaSerGlyProThrTrpLysValGlnArgSerGlnAsnProLeuLysIleArgLeuthrArgGlyAlaPro end polyerese
2 ProProAlaGluSer * * Arg * * * * * * * * * * * * * * * ThrSer end polywerase
env polypeptide * AlaCysSerThrLeuPro * SerPro * * * * Asp * ArgAspLeu * * Pro * Ile
C..C..G...A.T. CGT..T..A..C..C. T...C..G C...A..T. CCC.T.AATCC
FIG. 3. Nucleotide sequence of the 3' ends of the polgenes and the 5' ends of the enm genes of F-MCFV (pFM54B) and F-MuLV. The ami-
no acids of the frames for polymerase and env polypeptide are also given. Dots indicate identical nucleotides and asterisks denote identical
amino acids in F-MuLV when compared to F-MCFV.
is highly leukemogenic, the presence of a large direct repeat
in U3 apparently is not necessary for the leukemogenic
potential of MCFVs. When we compared polytropic viruses
F-MCFV and M-MCFV with the ecotropic viruses F-MuLV
and M-MuLV, we did not observe a single nucleotide which
was specific for either polytropic or ecotropic viruses. Thus,
we assume that the sequences responsible for the expanded
host tropism of MCFVs are not located in the LTR but in
another part of the genome (see below).
We compared the LTRs of the Friend viruses with those of
Moloney viruses. We found certain positions (e.g., the
region between nucleotides 2093 and 2115 or between nucle-
otides 2188 and 2192 of F-MCFV) (Fig. 4) which are different
between these two groups of viruses. Recent experiments in
other laboratories have suggested that the LTR plays a
crucial role in determining the type of disease caused by
different leukemia viruses (4, 9). The differences in the LTRs
described above may be the molecular basis for these
properties. Friend SFFV (F-SFFV) is an erythroleukemia-
inducing virus. The LTR of F-SFFV (6) is nearly identical to
the LTR of F-MCFV (comparison not shown). Therefore,
the LTR sequence differences between F-MCFV and the
Moloney viruses could be determinants of erythroid versus
lymphoid virally induced leukemia. However, when the
LTR sequence of AKR MCF247 (a virus which accelerates
T-cell leukemia in AKR mice) (19) was also examined
(comparison not shown), only some of these nucleotide
differences remained. These sequences are indicated by an
arrow in Fig. 4.
Comparison of the env genes of pFM54B and pFMI/pFM2.
Figure 2 shows the composition of the nucleotide sequences
obtained for the F-MCFV clones pFM54B, pFM1, and
pFM2. The sequence of pFM54B has one large open reading
frame consisting of 2,028 nucleotides. This frame starts at
nucleotide 28 and terminates at position 2055 with two stop
condons. The amino acid sequences for this reading frame
starting at the first ATG codon are also shown in Fig. 2.
The sequence coding for the peptide leader of the env
polyprotein in pFM54B and pFM2 consists of 32 codons.
There are seven nucleotide differences in this region of these
MCFV clones, five of which give rise to a change in the
corresponding amino acid. The open reading frame which
encodes gp70 encompasses 1,197 nucleotides (399 codons) in
pFM54B and 1,224 nucleotides (408 codons) in pFM1/pFM2.
In the sequence coding for the proline-rich region (PR) of
gp70 (see below), 27 nucleotides (nine codons) are deleted in
pFM54B at position 978. In the gp7O's of pFM54B and
pFM1, 103 (8.6%) nucleotide differences exist leading to 33
(8.3%) amino acid changes (including the deletion of 27
nucleotides). Nineteen of these nucleotide changes (11 ami-
no acid changes) are situated in the env sequence from the
initiation codon up to the end of the PR (differential region,
see below), whereas 84 nucleotide changes (22 amino acid
changes) occur in gp7O downstream of the PR.
The 27 nucleotides in the PR of pFM1 which are deleted
from pFM54B are present in other polytropic viruses (3, 25;
C. Holland, personal communication) and in F-SFFV (1, 6,
58). Interestingly, this deletion in pFM54B gives a portion of
the PRs which are different in F-MCFV and F-MuLV
(positions 943 to 963 in pFM54B in Fig. 5A) the exact same
length between stretches which are homologous in the two
env genes. In vitro recombinants of F-MuLV containing the
env gene of pFM54B yielded infectious but nonpathogenic
virus (unpublished data). It is possible that this deletion is
responsible for the nonpathogenicity of this clone. Experi-
ments are in progress to test the importance of these deleted
sequences in causing disease.
Comparison of the env genes and env polypeptides of F-
MCFV and F-MuLV. Figures SA and B show the 3' termini
of the pol and env genes of F-MCFV (pFM54B) and F-
MuLV (pF-MuLV57). Also shown are the amino acid se-
quences of the env polypeptides. Alignment was performed
to obtain maximal homology of the two nucleotide se-
quences.
Comparison of the nucleotide sequences of F-MCFV
(pFM54B) and F-MuLV show identical sequences in the pol
gene of both viruses up to nucleotide 36. The two viral
sequences then vary up to nucleotide 1509 in F-MCFV. We
therefore conclude that the nucleotides between positions 36
and 1650 in F-MuLV have been replaced by endogenous
sequences, thereby forming F-MCFV (clone pFM54B). The
substitution begins in the 3' portion of the pol gene about 120
nucleotides upstream from the initiator ATG of the env gene
and ends at or near nucleotide 1510 (in F-MCFV) within the
sequence coding for pl5enh. The substituted sequence in F-
MCFV (pFM54B) is 141 nucleotides shorter than the corre-
sponding F-MuLV sequence. The two env genes share the
same initiation and termination codons and are translated in
the same reading frame.
Within the region coding for p15en , the nucleotide se-
J. VIROL.
 at Universitaetsbibliothek M
uenchen on August 4, 2008 
jvi.asm.org
D
ow
nloaded from
 
F-MCFV ENVELOPE GENE AND LTR 833
* * * * - I. ? 0
1 F-fCP' GAGCCAT GATAAAATAAAAGATTTTATTTAGTTTCCAGAAAAA GGGGGGAATGAAAGACCCC ACCAAGTTGCTTAGCCTG
'? )r-N sr ................................
. . ......... .
.................... . .. ............ .............3 -cp..k.' -..... A............... ................ TGTAG.T ..G. .AA.
4 g-uz. .... A C
...............
... TGTAG.T. .G. .AA.
GluPro end pfSenv inverted repeat AA Ak
I ATAGCCGCAGTAACGCCATTTTGCAAGGCATGGAAAAATACCAAACCAAGAATAGGGAAGTTCAGATCAAGGGCGGGTACACGAA AACA
2. . A. T.A....
C... TTA.AT..... .. ..... . ... TG .A.T.A.,A... GATGG....
4 C.... TT.T.A......A .TG. A T.A. .A...GATGG.
f GCTAACGTTGGGCCAAACAAGATATCTGCGGTAAGCAGTTTCGGCCCCGGCCCGGGGCCAAGAACAGAT
2 ................. G..... T . AC GC TGGGCCA
... G.ATA. G. T. C.T. T.A.
4.. G.ATA. G . T C.T. T.A........... GGAACAGCTGAATATGGGCCA
I GGTCCCCAGATATGGCCCAACCCTCAG
2 AACAGGATATCTGTGGTAAGCAGTTTCGGCCCGGTCGGCCCCGGCCCGAGGCCAAGAACGGAT...........................
.7 ........... GC..T...G.......
4 AACAGGATATCTGTGGTAAGCAGTT CCTGCCCCGGCTCAGGGCCAAGAACAGAT...........GC..T. .. G.
* ~~AAA -A
I CAGTTTCTTAAGACCCATCAGATGTTTCCAGGCTCCCCCAAGGACCTGAAATGACCCTGTGCCTTATTTAAATTAACCAATCAGCCCGCT
2 G....G...................
3. AG...A.. G.G....C.. ..C ........... TT
. AG..A..G.G G .C.. TT ...
A A CAT box
* *.. . . D3 < , r R ,I
1 TCTCGCTTCTGTT1CGCGCGTTTTGCTTCCCGAGCTCTATAAAAG AGCTCACAACCCCTCACTCGGCGCGCCAGTCCT ACAGACTGA
2 ............ C....................................................... CCG.T.
.7 .......... C....C........ A..........C........ T.................... CCG.TT.
4
.... . . . . ....... j..C .. .C. . . . .A ..... . .. C.. . . . . . . . G . . . . ..CCG.TT . . .
Z DA' A TATA box
I GTCGCCCGGGTACCCGTGTATCC AATAAA TCCTCTTGCTGTTGCATCCGACTTGTGGTCTCGCTGTTCCTTGGGAGGGTCTCCTCAGAGT
2 .A.TC ........ ...... ........ ...................
.7.A ... ........ A..................................AT.
poy(A,) signal
. wrs .0- . . . .
I GATTGACTACCCGTCT CGGGGGTCTTTCATTtTGGGGGCTCGTCCGGGAT CTGGAGACCCTTGCCCAAGGACCACCGACCCACCACCGGG
2 .............
.........................
........................................G...... ........
if
. . .. . . .
AG
........... .............. . . . . G........C..... G .................. ....
Iinvarted raeaot priror biinding site
1 AGGTAAG CTGGCCAGCAATTGATCTGTGTCTGTCC ATTGTCCCGTG
2 ............................ ............. .............TCTTTGATTGATTTTATGCGCCTGCGTTTGTACTAGTTGGCCG
4 1............... C.T..........C..T G ....TA ..TCTATGACTGATTTTATGCGCCTGCGTCGGTACTAGTTAGCTA
splice donor
2107
2248
2396
7846
2196
2337
2486
7936
2264
2417
2555
8026
2291
2507
2582
8107
2381
2597
2672
8197
2468
2687
2762
8287
/23
2558
2777
2852
113
2647
2866
2882
203
2693
2955
293
FIG. 4. Nucleotide sequences of the LTRs and adjacent regions of F-MCFV (pFM54B), F-MuLV, M-MCFV (3), and M-MuLV (46). The
sequences were aligned to obtain maximal homology. Arrows denote some of the differences between lymphatic leukemia- and
erythroleukemia-inducing viruses (see text). Dots indicate identical nucleotides as in F-MCFV. Gaps have been introduced to allow optimal
alignment. Regions of functional importance are enclosed in boxes. Direct repeats are underlined. Position numbers for M-MCFV and M-
MuLV are taken from references 3 and 46, respectively.
quences of F-MCFV (pFM54B) and F-MuLV are identical
from nucleotide 1510 to nucleotide 2112 (5' terminal portion
of the U3 region in the LTR) with one exception: a change at
nucleotide 1693 in the region encoding p15el' in F-MCFV
leads to an arginine, whereas F-MCFV carries a glycine at
the corresponding position. In all MCFVs studied so far, the
borders of the substituted regions can be recognized by a
change from complete homology (outside the recombination
site) to sequence variations (within the recombination sites).
Since the change at position 1693 in F-MCFV is located far
downstream (180 nucleotides) from the proposed recombina-
tion site of F-MCFV and F-MuLV (see below), we suggest
that this difference is due to a point mutation which occurred
after the generation of F-MCFV.
The substitution in pFM1/pFM2 is considerably shorter
than that in pFM54B. It begins within the sequence coding
for the peptide leader at or near nucleotide 166 in F-MuLV
(Fig. 5A) and ends near position 1211. There are few
nucleotide differences between pFM1/pFM2 and F-MuLV
clone 57 outside the substituted region (e.g., positions 173,
175, 1152, 1161, 1191, and 1227; Fig. 2). Since pFM1/pFM2
are derived from a Friend virus-infected cell line of an STU
mouse (44) and not from F-MuLV clone 201 as are pFM54B
and pF-MuLV57, we consider these differences to represent
point mutations present in the progenitor MCFV of
pFM1/pFM2.
The env gene product of F-MCFV (pFM54B), as deduced
from the nucleotide sequence, is 636 amino acids long
(including the deleted sequence in the PR; Table 1). This is
39 amino acids shorter than the proposed env polypeptide
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A xo
Priand-NACf AACTAAAAATCTAGAACCCCGCTGGAAAGGACCCTACACCGTCCTGCTGACCACCCCCACCGCTCTCAAAGTAGACGG 78
~ zLtf...........T.........................A.T... .... 78
differential region: r-£L 151
CATCGCTGCGTGGATCCACGCCGCTCACGTAAAAGCGGCGACAACCCCTCCGGCCGGAACAGCATCAGGACCGACATGGAAGGTCCAGCG 168
M4etGluGlyProAla
* AlaCysSerThr
.... T. ....... G.T. .CGAC .. AGGATT.AGCC.C.... ..A.T. CGT .T..A.. 165
TTCTCAAAACCCCTTAAAGATAAGATTAACCCGTGGGGC CCCCTGATAGTCCTGGGGATCTTAATAAGGGCAGGAGTATCA 249
-27 PheS*rLysProLe dysAspLysIlTsnProTrpGly ProLeuIleValLeuGlyIleLeuIleArgAlaGlyValSer
-30 LeuPro * SerPro Sp*P * ArgAspLeuLeuIle * * * LeuPheLeuSer * LyaGly * ArgSerAla
C C .. T...C.G....C . A.CTCCTAATC ... T.A .TC. .T.CCT.TCTC.C.A.G... CA. .TCCG.. 255
L... gp70
GTACCACATGACAGCCCTCATCAGGTCTTCAATGTTACTTGGAGAGTTACCAACTTAATGACAGGACAAACAGCTAATGCTACCTCCCTC 339
1 ValProHisAs er roHisGlnVa PheAsnValThrTrpArgValThrAsnLeuMetThrGlyGlnThrAlaAsnAlaThrSerL*u
2 Ala * GlySer*** *|Tyr * le * * Glu * * * GlyAspArgGlu * ValTrp * Ile * Gly
.C... CGGCTC. C. ...... .... .....G.. . T GG.GATC.GG.G .... TATGG ..A.TA. .AGG.. 342
CTGGGGACAATGACCGATGCCTTTCCCAAACTGTACTTTGACTTGTGCGATTTAATAGGGGAC 402
31 LeuGlyThrlletThrAspAlaPheProLyaLeuTyrPheAspLeuCysAspLeuIleGlyAsp
31 AanHisProLeuTrpThrTrpTrp * Val * ThrPro * * * tlet * AlaLeuSerGlyProProHisTrpGlyLeuGluTyr
AACCACC.TC ..TGGAC.TGG.GG ..AGTC.. CAC.CCA ....T TATG.. GCTCTCAGTGGGCCGCCCCACTGGGGGCTAGAGTAT 432
GACTGGGATGAGACT 417
AspTrpAspGluThr
61 GlnAlaProTyrSerSerProProGlyProProCyaCyeSerGlySerSerGlySerSerAlaGlyCyaSerArg * Cys * * Pro
CAGGCCCCCTATTCCTCGCCCCCGGGGCCCCCTTGTTGCTCAGGGAGCAGCGGGAGCAGTGCAGGCTGTTCCAGA .C..C... C.C 522
GGACTCGGGTGTCGCACTCCCGGGGGAAGAAAAAGGGCAAGAACATTTGAC TTCTATGTT 477
57 GlyLeuGlyCysArgThrProGlyGlyArgLysArgAlaArgThrPheAsp heTyrVal
91 LeuThrSerLeuThrProArgCysAanThrAlaTrpAsn * LeuLyaLeuAspGlnValThrHiaLysSerSerGluGl * * *
TTGAC.TCCCTCAC.C ... GGT.CAAC.CTGCCT ..AAC.. CTTAAGCTAGACCAGGTAACTCATAAATCAAGTGAGGGA.. .....T C 612
TGCCCCGGGCATACTGTACCAACAGGG TGTGGAGGCCCGAGAGAGGGCTACTGTGGCAAATGGGGCTGTGAGACCACTGGA 558
77 Cy iProGli&sThrValProThrGly TysGlyGlyPrArgGluGlyTyrCysGlyLysrpGlyCyGluThrThrGl
121 ** SerHisArg * ArgGluAlaLysSer* ***| AspSerPhe * * AlaSerL** *i*
......... TCACA.CGC. .CCGG.AAGCCAAGTCC........T.AGACTCCTT........ C.TCT.... C. A. .C. .T 702
CAGGCATACTGGAAGCCATCATCATCATGGGACCTAATTTCCCTTAAGCGAGGAAACACCCCTCGGAATCAGGGCCCCTGTTATGATTCC 648
104 GinAla TyrTrpLysProSerSerSerTrpAsp.euIleSerLeuLysArgGlyAanThrProArgAanGlnGlyProCyaTyrAspSer
151 ArgVal| * * * * * * * * *
_Tyr * ThrValAspAsnAanL.u * Thr *
AGA.T.C. .C..C.CT.. TAC . CA.AG.GG.CAACAATCT .. A.. AG. 768
TCAGCGGTCTCCAGTGGCATCCAGGGTGCCACACCGGGGGGTCGATGCAATCCCCTAGTCCTAGAATTCACTGACGCGGGTAAAAAGGCC 730
134 SerAlaValSerSerGlylleGlnGlyAlaThrProGlyGlyArg ysAsnProLe*ValLeuGluPheThrAspAlaGlyLyaLysAla
173 Gln * * GlnValCyaLysAspAsnLysTrp * * .*. jlaIleGln * * Asn * * * GlnVal
CAG ..T .. CAGGTAT.. .AAG.CAA.AAGTGG ......... T.G.CTA.CC.G . T. AA.... C. ... C... TT. 846
AGCTGGGATGGCCCCAAAGTATGGGGACTAAGACTGTACCGATCCACAGGAACCGACCCGGTGACCCGGTTCTCTTTGACCCGCCAG 825
164 SerTrpAspGlyProLyaVal rpGlyLeuArgLeuTy ArgSerThrGlyThrAapProValThrArgPheSerLeuThrArgGln
199 Thr * * ThrThrGlyHisTyrl* * * * ** aVl * * Arg * * GlyLeuThr * GlyIleArgLeuArg
ACCTCA ... ACAACTGGAC.CTAT ..... ... TC.T .T. .TGTC ..T ..GCGG....... G.CTTACT . GGGA.CCGA.T.AGA 933
GTCCTCAATATAGGGCCCCGCATCCCCATTGGGCCTAATCCCGTGATCACTGACCAGTTACCCCCCTCCCGACCCGTGCAGATCATGCTC 915
193 ValLeuAsnIleGlyProArgIl eGlyProAsnProVaalleThrAspGlnLeuProProSerArgProValGlnhleletLeu
228 TyrGIn * Lou * * * V,l ..*.** * * * * LeuAla * * * SerLeuPro * * AsnPro *
TAT.AA.. C.... .A..T. .GG .. G. .A. .A. .GC..C. CC.GG.A..... AC.TT.G.T.C.G..... TAAT.CC ..A 1017
end differential region - - - -
CCCAGGCCTCCTCAG CCTTCCCCTACAGGCGCAGCCTCTATACAACCTGGG 966
223 ProArgProProGln |roSerProThrlyAlaAlaSerIleGlnPr ly
256 * Lys * AlaLysSerProProAlaSerAsnSerThrProThrLeul 1eSe rI* *roThrGlnProProProAlaLL
.....AA.. G.CA ..TCTCCCCCCGCCTCTAATTCGACTCCCACATTGATTTCC ..G.....GC.TCC.A.TCAGC.CCCG.C.G.A. .A 1107
---con"tent region .
ACGGGAGACAGACTGCTAAACCTGGTAGATGGAGCCTACCAAGCACTCAACCTCACCAGTCCTGACAAAACCCAAGAGTGCTGGTTGTGT 1056
240 ThrGlyAspArgLeuLeuAsnLeuVa An IyAlaTyrG1nAlaLeuAsnLeuThreris roAspLysThrGlnGluCysTrpLeuCys286 * * * * *G1rn_* * * * * * * * * IAs4 * * * * * * * * * *
...........
GT.A. T.. A. ..C.G. T. G. T
....AC.T.T.. .C 1197
FIG. 5
chain of F-MuLV (675 amino acids). Most of the differences uncharged, mostly apolar amino acids is found. The conser-
in the env polypeptides of F-MCFV and F-MuLV are located vation of this hydrophobic region points to the important
in the leader peptide and in gp7O, whereas p15e'7' is highly function of the signal peptide in the excretion of the env
conserved. The proposed signal peptides of the env precur- polypeptide through cell membranes.
sor polypeptides of F-MCFV and F-MuLV consist of 32 and The signal peptide cleavage site of the F-MuLV precursor
34 amino acids, respectively. The nucleotide and amino acid polypeptide has been determined (23), whereas this site is
sequences of the F-MCFV leader peptide are very different not known for F-MCFV. In Rauscher MCFV, the mature
from those of the parental F-MuLV. However, in this gp7O polypeptide chain starts with NH2-Val-Gln-His-Asp
portion of the env polypeptide of both viruses, a stretch of (44). We therefore assume that the mature gp7O of F-MCFV
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B end differential region-f r-- -6
Frfond-ZCFt CAG CCTTCCCCTACAGGCGCAGCCTCTATACAACCTGGG 966
Gln ProSerProTh GlyAlaAlaSer1lelnProGly
LysSerProProAlaSerAsnSerThrProThrLeulleSer * * * * oThrGInProProProAl *
Fr&Land-X.u. A ..TCTCCCCCCGCCTCTAATTCGACTCCCACATTGATTTCC ..G.....GC.TCC.A.TCAGC.CCCG.C.G.A ..A 1107
--- constant reion
ACGGGAGACAGACTGCTAAACCTGGTAGATGGAGCCTACCAAGCACTCAACCTCACCAGTCCTGACAAAACCCAAGAGTGCTGGTTGTGT 1056
240 ThrGlyAspArgLeuLeuAsnLeuValAspGlyAlaTyrGlnAlaLeuAanLeuThrSerProAspLysThrGlnGluCysTrpLeuCys
286 * * * * * * * * * Gln * * * * * * * * * Asn * * * * * * * * * *
........... GT.A. T. ... TC.G. T. G. T . AC..T. T..A.C 1197
CTGGTATCGGGACCCCCCTACTACGAAGGGGTTGCCGTCCTAGGTACCTACTCCAACCATACCTCTGCCCCAGCTAACTGCTCCGTGGCC 1146
270 LeuValSerGlyProProTyrTyrGluGlyValAlaValLeuGlyThrTyrSerAsnHisThrSerAlaProAlaAanCysSerVaiAla
316 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
.. A. G. T ........... T .. . . .. . . .. . . . ... T.. ...... . . . . . . . . . . . . . . . . 1287
*G T 1287
TCCCAACACAAGCTGACCCTGTCCGAAGTAACCGGACAGGGACTCTGCGTAGGAGCAGTTCCCAAAACCCATCAGGCCCTGTGTAATACC 1236
300 SerGlnHisLyaLeuThrLeuSerGluValThrGlyGlnGlyLeuCysValGlyAlaValProLysThrHisGlnAlaLeuCysAsnThr
346 * * * * * * * * * * * * Arg * * * lie * Thr * * * * * * * * * * *
............
T.
. ............ G. T ... G... .. .. A ... A . . C. A . ..T. C .. . . . . C. T 1377TG*T. . .G .. .C .CC C..
ACCCAGAATACAAGCGACGGGTCCTACTATCTGGCTGCTCCCGCCGGGACCATTTGGGCTTGCAACACTGGGCTCACTCCCTGCCTATCT 1326
330 ThrlnAsnThrSerAS lySerTyrTyrLeuAlaAlaProAlaGlyThrIleTrpAlaCysAsnThrGlyLeuThrProCyaLeuSer
376 * .euLysIleAspLys* * * * * Val * * Thr * * Thr * * * * * * * * * * * *
.... TT ..G.T.GA.A.A. T. A.T . C.. A.A .A ..T.CG. A.T.. A. A.1467
ACTACTGTACTCAACCTCACCACCGATTACTGTGTCCTGGTTGAGCTCTGGCCAAAGGTGACCTACCACTCCCCTGGTTATGTTTATGGC 1416
360 ThrThrValLeuAsnLeuThrThrAspTyrCysValLeuValGluLeuTrpProLysValThrTyrHisSerProGlyTyrValTyrGly
406 Ala * * * * Arg * * * * * * * * * * * * Arg * * * * Pro * Ser * * * Ser
G.C. .C. .G. .T. .T.G. . .C..T. .C. .T. .C.A... T.A. C.G . C. TC.T. .CA... .C. ... A.. 1557
end gpZgO - r-,pi5env,pi2env
CAGTTTGAGAGAAAAACCAAATATAAAAGAGAGCCGGTGTCATTAACTCTGGCCCTGCTGTTGGGAGGACTTACTATGGGCGGCATAGCT 1506
390 GlnPheGI |rgiLysThrLysTyjLysArgGluProValSerLeuThrLeuAlaLeuLeuLeuGlyGlyLeuThrfetGlyGlylleAla
436 * * * LysSerTyrArgHi * * * * * * * * * * * * * * * * * * * * * *
........ A.A.TCCTAT.G.C.A.A. C. CT. AT.A .A..T..G.A.A. T. C. .C 1647
GCAGGAGTAGGGACAGGAACTACCGCCCTGGTCGCCACCCAGCAGTTCCAGCAGCTCCATGCTGCCGTACAAGATGATCTCAAAGAAGTC 1596
420 AlaGlyValGlyThrGlyThrThrAlaLeuValAlaThrGlnGInPheGInGInLeuHisAlaAlaValGlnAspAspLeuLysGluVal
466 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
..G .... 1737
GAAAAGTCAATTACTAACCTAGAAAAGTCTCTTACTTCGTTGTCTGAGGTTGTGCTGCAGAATCGACGAGGCCTAGACCTGTTGTTCCTA 1686
450 GluLysSerIieThrAsnLeuGluLysSerLeuThrSerLeuSerGluValValLeuGlnAsnArgArgGlyLeuAspLeuLeuPheLeu
496 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
.......................................................................................... ....................................................1827
AAAGAAAGAGGACTGTGTGCTGCCCTAAAAGAAGAATGTTGTTTCTATGCTGACCATACAGGCCTAGTAAGAGATAGTATGGCCAAATTA 1776
480 LysGluArgGlyLeuCysAlaAlaLeuLysGluGluCysCysPheTyrAlaAspHisThrGlyLeuValArgAspSerMetAlaLyaLeu
526 * * Gly * * * * * * * * * * * * * * * * * * * * * * * * * * *
...... .... 1917
AGAGAGAGACTCACTCAGAGACAAAAACTATTTGAGTCGAGCCAAGGATGGTTCGAAGGATTGTTTAACAGATCCCCCTGGTTTACCACG 1866
510 ArgGluArgLeuThrGinArgGInLysLeuPheGluSerSerGInGlyTrpPheGluGlyLeuPheAsnArgSerProTrpPheThrThr
556 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
.......................................................................................... ....................................................2007
TTAATATCCACCATCATGGCGCCTCTCATTATACTCCTACTAATTCTGCTTTTTGGACCCTGCATTCTTAATCGATTAGTTCAATTTGTT 1956
540 LeulleSerThrIleMetGlyProLeulleIleLeuLeuLeulieLeuLeuPheGlyProCysIleLeuAsnArgLeuVaIGInPheVal
586 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
.................................................................. . ..................2097
end pi2env-1 . . end piJenv -
AAAGACAGGATCTCAGTAGTCCAGGCTTTAGTCCTGACTCAACAATACCACCAGCTAAAACCACTAGAATACGAGCCATGATAAATAAAA 2046
570 LysAspArgIleSerValValGlnAlaLeuValLeuThrGlnGlnTyrHisGInLeuLysProLeuGluTyrGluPro
616 * * * * * * * * * * * * * * * * * * * * * * * * * *
.......................................................................................... 2187
. rLT2R
GATTTTATTTAGTTTCCAGAAAAAGGGGGGAATGAAAGACCCCACCAAGTTGCTTAGCCTGATAGCCGCAGTAACGCCATTTTGCAAGGC 2136
.................................................................. 27.......................2277
FIG. 5. Nucleotide sequences and deduced amino acid sequences of the enm genes of F-MCFV (pFM54B) and F-MuLV (pF-MuLV57)
(20). The two nucleotide sequences were aligned to obtain maximal homology. Asterisks indicate identical amino acids in F-MuLV with
respect to F-MCFV. Gaps have been introduced to allow optimal alignment. (A) 5' portions of the env genes and their products of F-MCFV
and F-MuLV representing the differential region (see text). Stretches of identity (at least four identical amino acids) between the two env
polypeptides are enclosed in boxes. (B) 3' portions of the env genes and carboxy-terminal portion of the env polypeptides of F-MCFV and F-
MuLV representing the constant region (see text). Stretches of divergence (at least five different amino acids) between the two enm
polypeptides are enclosed in boxes.
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begins with the related sequence NH2-Val-Pro-His-Asp. The
carboxy terminus of gp7O of F-MCFV has been located by
analogy to F-MuLV (20).
The amino acid sequences of F-MCFV and F-MuLV are
very different in the amino-terminal portion of gp70 up to
position 238 (in F-MCFV) (Fig. 5A). We call the env gene
sequence up to position 963 in F-MCFV the differential
region, since only a few stretches of identity between F-
MCFV and F-MuLV can be detected (boxes in Fig. 5A).
Starting at amino acid 239 in F-MCFV, the carboxy-
terminal regions of gp7O in F-MCFV and F-MuLV are very
similar (Fig. SB). In this constant region, only two stretches
with significant differences (boxes in Fig. 5B) are present.
The env precursor polypeptides of F-MCFV, F-MuLV
(20), and other mammalian retroviruses (3, 11, 22, 46;
Wunsch et al., in press) contain stretches of uncharged,
mostly nonpolar amino acids located in homologous regions.
The apolar regions of F-MCFV are underlined in Fig. 2.
Some of these regions could allow polypeptides to penetrate
through or integrate in cellular and viral membranes accord-
ing to the model proposed by Lenz et al. (22).
Possible role of the PR of gp7O. The gp7O's of all MCFVs
and MuLVs examined to date and the gp52 of F-SFFV
contain a region strongly enriched in proline residues (PR) at
the carboxy terminus of the differential region. In Fig. 6, the
PRs of two F-MCFVs, M-MCFV (3), F-SFFV (6, 58), F-
MuLV (20), M-MuLV (46), and Akv (22) are compared. In
these regions the relative amount of proline residues varies
between 31 and 36% depending on the virus. MCFVs and F-
SFFV have similar amino acid sequences in their PRs,
whereas the ecotropic MuLVs have different sequences
compared with the MCFVs and F-SFFV. The PRs of all
ecotropic MuLVs include a stretch of about 35 amino acids
where the gp7O's of these viruses are remarkably different
with respect to each other (20) (hypervariable region of
ecotropic gp70's; see below). As discussed previously (20),
the different amino acid sequences of the PRs of the gp7O's
of ecotropic MuLVs could allow these viruses to interact
with specific receptors, thus defining the host range of these
viruses.
The PR of clone pMo-MCF-16 (3) of the lymphatic leuke-
mia-inducing M-MCFV and the PR of clone pFM1 of the
erythroleukemia-inducing F-MCFV are nearly identical.
Therefore, we can exclude the possibility that this region is
involved in determining the histological type of disease
caused by MCFVs. Rather, the PR might be responsible for
the polytropic host range of the MCFVs. It could carry the
sequences utilized by xenotropic and polytropic viruses for
TABLE 1. Calculated molecular weights of proposed F-MCFV
env polypeptidesa
No. of amino Mol wt of the
Polypeptide acid residues apopolypeptide
Total env precursor 636 69,155
polypeptide
N-terminal signal 32 3,396
peptide
gp7O 408 43,944b
plSenv 196 21,834
pl2env 180 19,867
a Clone pFM54B was taken for calculation; however, the se-
quence of 27 nucleotides which is deleted in the PR of this clone was
added before calculation.
b Since some amino acids might be cleaved off the carboxy
terminus of gp7O, the actual number might be slightly smaller.
interaction with cell surface receptors. An examination of
the env sequences of recombinant MuLVs with ecotropic
host ranges (36, 38) would clarify this point.
Comparison of the amino acid sequences of env polypeptides
of different viruses. Figure 7 shows a comparison of the
amino acid sequences of the env polypeptides of F-MCFV
(pFM54B, pFM1, and pFM2), M-MCFV (3), F-SFFV (6, 58)
and F-MuLV (20). The sequences of the env polypeptides of
the MCFVs and F-SFFV have a high degree of similarity. As
described above, the sequence of the F-MuLV env polypep-
tide ranging from the leader peptide to the carboxy terminus
of the PR is dissimilar with respect to the MCFV and F-
SFFV sequence (differential region; Fig. 5A). F-MuLV and
these other viruses have very similar polypeptide sequences
from the carboxy terminus of the PR region up to the end of
pl5env (constant region; Fig. SB). At the carboxy terminus,
the p15enl-related sequence of F-SFFV gp52 is 33 amino
acids shorter than the plSenV of F-MCFV, M-MCFV, and F-
MuLV. The carboxy-terminal six amino acids of gp52 are
different with respect to the plSenvl of the other viruses,
which have a common sequence in this region.
Localization of possible glycosylation sites. Asn-X-Thr/Ser
sequences are known to be possible sites for glycosylation of
retroviral polypeptides (13, 29). Glycosylation sites within
the env gene products are highly conserved within different
host range classes of mammalian retroviruses (3, 11, 20, 22,
46; Wunsch et al., in press). This argues for a strong
selective pressure in favor of their conservation. The gp70's
of F-MCFV, M-MCFV, and F-MuLV carry six potential
glycosylation sites in homologous positions (boxes in Fig. 7).
The three amino-terminal sites are also contained in gp52 of
F-SFFV, whereas the three carboxy-terminal sites are de-
leted in F-SFFV. F-MCFV has one additional possible
glycosylation site (at amino acid 26) shared by F-MCFV and
F-SFFV and one site (at amino acid 332) not found in M-
MCFV or F-SFFV. F-MuLV has two additional sites (at
amino acids 168 and 266) not found in these other viruses.
Whether all of the potential sites in the gp7O's and gp52 are
glycosylated is unknown at present. The sequence Asn-Arg-
Ser in plSenv of the env polypeptides of murine retroviruses
is not glycosylated (28, 37, 57).
General structure of the env gene. Comparison of murine
retrovirus env genes and their products shows that they are
composed of clearly distinguishable regions (Fig. 5A, 5B,
and 7). The sequence between the amino terminus of the
leader peptide and the end of the PR is highly conserved
within the polytropic group of viruses and within the ecotro-
pic viruses but very different between polytropic and ecotro-
pic viruses (differential region). The remainder of the env
polypeptide is composed of a region which is very similar
between polytropic and ecotropic viruses (constant region).
A comprehensive view of the elements of the env polypep-
tide is given in Fig. 8.
A few sections of the differential region are homologous
between the ecotropic and polytropic viruses (boxes in Fig.
SA, dotted areas in Fig. 8). The constant regions contain two
blocks with variable character (boxes in Fig. SB, white areas
in Fig. 8).
As described above, the PR is located at the border of the
differential and constant regions. In the env polypeptides of
all ecotropic mouse viruses studied so far, the PR is the only
larger segment with considerable variability. The total env
polypeptide seems, therefore, to consist of the following
elements: differential region (without PR), PR, and constant
region. The structure of the env polypeptide is reminiscent of
the structure of the immunoglobulins which consist of sepa-
J. VIROL.
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FIG. 6. PRs in the gp7O's of F-MCFV (clones pFM1 and pFM54B), M-MCFV (3), F-MuLV (20), M-MuLV (46) and Akv (22) and in the
gp52 of F-SFFV (6, 58). The standard one-letter amino acid code is used. Dots indicate identical amino acids with respect to F-MCFV clone
pFM1. Proline residues are underlined. Gaps have been introduced to allow optimal alignment. The numbering of the amino acids of the
individual sequences refers to their positions in gp7O (or gp52).
rate genetic elements: variable region, PR (hinge), and
constant region (17, 55).
It has been suggested recently (Wunsch et al., in press)
that the constant portions of gp7O and p15e?l' of mammalian
retroviruses are two separate genetic elements which togeth-
er with the N-terminus of the differential region can be
traced to a common short primordial env-related gene. We
have proposed that the present day env gene has been
generated by at least two tandem duplications of this primor-
dial env-related genetic element and by additional recombi-
national exchanges and mutations.
Possible functions of the elements of the env gene and its
products. Comparison of the putative points of recombina-
tion which have led to the generation of MCFVs shows that
the differential region is the part of the env gene in all
MCFVs which is replaced by endogenous sequences. In
some viruses, e.g., clone pFM1/pFM2 of F-MCFV, little
more than the differential region has been substituted. We
therefore assume that the differential region is the part of the
env gene which determines the ecotropic or polytropic host
range of the virus. As described above, the PR may contain
determinants for this function.
Various parts of the constant region have been replaced by
endogenous sequences in the env genes of the MCFVs
analyzed so far. These endogenous sequences are very
similar to their ecotropic partners: pFM1 carries only three
and pMo-MCF1-16 carries only four varying amino acids in
this part of the constant region. Thus, we can assume that
the constant regions of ecotropic and polytropic viruses
carry domains for those functions which are common to all
viruses, e.g., determinants for infectivity and structural
properties necessary for interaction with cellular mem-
branes.
Do MCFVs contain disease-specific sequences in their env
polypeptide? Since MCFVs induce the same type of disease
as their ecotropic progenitor viruses and since MCFVs are
believed to be the ultimate cause of these diseases, we tried
to identify sequences which are characteristic for particular
histological types of leukemia. It has been shown previously
(34) that a 2.4-kilobase-pair fragment of F-MuLV encom-
passing about 700 bp of the pol gene and almost the entire
env gene contains sequences which contribute to erythroleu-
kemia. Since the pol gene is not a likely candidate for
determining disease specificity (34), we restricted our analy-
sis to the env gene (Fig. 7 and Table 2).
We compared all of the available data on amino acid
sequences of the env polypeptides of murine retroviruses
which cause either lymphatic leukemia or erythroleukemia.
TABLE 2. Comparison of amino acids at selected sites of different viruses
Amino acids at the following positions"
Region Virus Reference
27 139-141 181 200-201 253 282 514 523 550 553
Differential F-MCFV clone pFM54B This paper A G I Q T I P
F-MCFV clQne pFM1/2 This paper A D I K T V P
F-SFFV 6,58 A G V L T V P
F-SFFV 1 A G V Q I I P
M-MCFV 3 V N I K I V S
MCF247 C. Hollandb A D I K I V P
Constant F-MCFV clone pFM54B This paper Q V T S I L
F-MCFV clone pFM1/2 This paper Q V
F-SFFV 6,58 Q V T S I L
F-SFFV 1 Q V T S I L
M-MCFV 3 R I N T V M
MCF247 C. Hollandb Q V S Q I L
F-MuLV 20 Q V T S I L
M-MuLV 46 Q V N T V M
Akv 22 Q V S Q I L
a Positions refer to Fig. 7.
b Personal communication.
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FIG. 7. Comparison of the deduced amino acid sequences of the env polypeptides of F-MCFV (clones pFM54B, pFM1, and pFM2), M-
MCFV (3), F-MuLV (20), and the env-related polypeptide of F-SFFV (6, 58). The standard one-letter amino acid code is used. Sequences are
aligned to obtain maximal identity. Comparison of nucleotide sequences helped find proper alignment in some parts. Gaps have been
introduced to allow optimal alignment. Dots indicate identical amino acids with respect to F-MCFV (pFM54B). Possible glycosylation sites
are enclosed in boxes.
The following differences can be found among the clones
listed in Table 2 (differences between the F-MCFV clones
pFM1/pFM2 and pFM54B were regarded as not significant
and not taken into consideration; positions refer to pFM54B
of Fig. 7): positions 27, 139, 141, 181, 201, 253, 282, 292 to
486, 514, 523, 550, 553, and 591. The changes at positions 27,
139, 141, 181, 201, 253, 282, 514, 523, 550, 553, and 591 occur
in one or more of the lymphatic leukemia viruses (M-MuLV,
M-MCFV, Akv, or AKR MCF247) and in one or more of the
erythroleukemia viruses (F-MuLV, F-MCFV, or SFFV).
Since these changes occur in both types of viruses, they
cannot specify the type of disease produced by these agents.
Changes which lie between positions 292 and 486 fall into the
region of the F-MCFV genome which is deleted from the
SFFV genome.
These comparisons show that there is no site in the amino
acid sequence of the env polypeptide of different MCFVs
which clearly determines their disease specificity. We there-
J. VIROL.
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FIG. 8. General structure of env polypeptides of MCFVs. MuLVs. and F-SFFV. Differential region. PR, and constant region are explained
in the text. Arrows indicate the locations of the putative recombination sites involved in generation of MCFVs. Dotted areas represent
stretches of identical amino acids in F-MCFV and F-MuLV. White boxes are stretches of differing amino acids. Also indicated is the major de-
letion in F-SFFV. The length of the polypeptide is taken from F-MCFV(pFM54B).
fore must assume that the enm gene of a given MCFV cannot
contribute to different histological types of disease and that
other sequences in the MCFV genome are responsible for
determining what type of disease a particular virus will
induce.
We localized several nucleotide positions in the LTRs of
different viruses which seem to be characteristic of either
lymphatic leukemia- or erythroleukemia-inducing viruses
(see above). However, additional biological tests with in
vivo- or in vitro-generated recombinant viruses will be
necessary to determine the exact role these regions play in
determining pathogenicity and disease specificity.
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